Hikma Pharmaceutical | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Almirall EUR 1.46B 37.19M 2025-06
argenx SE 6.1B 597.47M 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Autolus Therapeutics Ltd 371.11M 56.22M 2025-03
Bayer EUR 32.58B 537M 2025-03
Fresenius EUR 19.41B 135M 2025-03
Galapagos EUR 2.64B 104.07M 2025-06
Genmab DKK 5.3B 31.4B 2025-03
GlaxoSmithKline GBP 14.35B 197M 2025-06
GRIFOLS EUR 7.6B 1.96B 2025-06
Hikma Pharmaceutical USD 2.32B 35M 2024-12
Lonza CHF 9.33B 23M 2024-12
Merck EUR 28.26B 1.64B 2025-06
Orion EUR 919.6M 147.2M 2025-06
Recordati EUR 1.87B 107.18M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
UCB EUR 10.03B 1.08B 2024-12


Hikma Pharmaceutical Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.